Triple Antigen vs Monoantigen Immunotherapy for Warts

Clinical trial NCT05254561 · COMPLETED

Trial details

NCT number: NCT05254561
Sponsor: Zagazig University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts

Start date: 2020-11-20
Primary completion: 2021-06-20
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.